REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,400,968 | +7.3% | 50,613 | +3.7% | 0.01% | +12.5% |
| Q2 2023 | $1,305,801 | +43.6% | 48,815 | +16.3% | 0.01% | +33.3% |
| Q1 2023 | $909,157 | +7.0% | 41,974 | +17.7% | 0.01% | 0.0% |
| Q4 2022 | $849,469 | +21.9% | 35,662 | +0.9% | 0.01% | +20.0% |
| Q3 2022 | $697,000 | +21.2% | 35,351 | +19.8% | 0.01% | +25.0% |
| Q2 2022 | $575,000 | -23.5% | 29,500 | +0.0% | 0.00% | 0.0% |
| Q1 2022 | $752,000 | -5.3% | 29,489 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $794,000 | -11.2% | 31,565 | -2.9% | 0.00% | -20.0% |
| Q3 2021 | $894,000 | -15.3% | 32,509 | -2.3% | 0.01% | +25.0% |
| Q2 2021 | $1,056,000 | -7.5% | 33,281 | +33.7% | 0.00% | 0.0% |
| Q1 2021 | $1,142,000 | +28.6% | 24,895 | +11.0% | 0.00% | +33.3% |
| Q4 2020 | $888,000 | +10.6% | 22,426 | -2.8% | 0.00% | -25.0% |
| Q3 2020 | $803,000 | +183.7% | 23,069 | +157.4% | 0.00% | +300.0% |
| Q2 2020 | $283,000 | +54.6% | 8,963 | +7.2% | 0.00% | 0.0% |
| Q1 2020 | $183,000 | – | 8,361 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $139,040,000 | 34.79% |
| Ponoi II Management, LLC | 685,011 | $17,242,000 | 31.32% |
| Nextech Invest Ltd. | 2,968,214 | $74,710,000 | 19.68% |
| Ponoi Management, LLC | 685,011 | $17,242,000 | 15.90% |
| Column Group LLC | 3,347,245 | $84,250,000 | 11.46% |
| TRV GP IV, LLC | 1,419,900 | $35,739,000 | 10.28% |
| Cormorant Asset Management, LP | 2,431,852 | $61,210,000 | 3.64% |
| Boxer Capital, LLC | 3,484,264 | $87,699,000 | 3.41% |
| Casdin Capital, LLC | 2,370,000 | $59,653,000 | 1.68% |
| BVF INC/IL | 1,810,549 | $45,572,000 | 1.65% |